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ABSTRACT
Osteoporosis is a polygenic disorder that is determined by the effects of several
genes, each with relatively modest effects on bone mass. The aim of this study was
to determine whether the vitamin D receptor single nucleotide polymorphism BsmI
is associated with bone mineral density (BMD) in Spanish postmenopausal women.
A total of 210 unrelated healthy postmenopausal women aged 60 ± 8 years were
genotyped using TaqMan® SNP Genotyping Assays. Lumbar and femoral BMD
were determined by dual-energy X-ray absorptiometry (DEXA). Daily calcium
and vitamin D intake were determined by a food questionnaire. No differences
were found in the femoral neck, trochanter, Ward’s Triangle, L2, L3, L4, L2-L4, or
between the femoral neck and total hip BMD after further adjustment for potential
confounding factors (P > 0.05) (age, BMI, years since menopause and daily calcium
intake). The BsmI polymorphism in the VDR gene was not associated with BMD in
Spanish postmenopausal women.
Subjects Diabetes and Endocrinology, Women’s Health, Medical Genetics
Keywords VDR polymorphism, BsmI, Postmenopausal, Osteoporosis
INTRODUCTION
Osteoporosis is a common disease characterized by low bone mass, disturbed microarchi-
tecture of the bone tissue, and increased fracture risk. Osteoporosis is defined to exist when
bone mineral density (BMD) values in the spine or hip fall 2.5 standard deviations (SD;
T-score values) or more below the population average in young adults (Kanis et al., 2002).
Peak bone mass is attained in early adult life but declines in postmenopausal women as a
result of a reduction in estrogen production with effects on bone as well as intestinal and
renal calcium handling (Prince & Dick, 1997).
Previous studies in twins and families showed that genetic factors play an important role
in the formation of BMD and that genetic influence can account for up to 85% of the bone
mass, with the strongest effects in the axial skeleton (Pocock et al., 1987; Christian et al.,
1989; Slemenda et al., 1991).
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Thus, osteoporosis is a polygenic disorder that is determined by the effects of several
genes, each with relatively modest effects on bone mass and other determinants of
fracture risk. Population-based studies and case-control studies have similarly identified
polymorphisms in several candidate genes that have been associated with bone mass or
osteoporotic fracture, including the vitamin D receptor (VDR) (Morrison et al., 1994),
estrogen receptor (Kobayashi et al., 1996), regulator genes of the synthesis of TGF-β1
(Langdahl et al., 1997) and collagen type I α-1 gene (Grant et al., 1996). Vitamin D, through
its principal bioactive form 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3), plays a crucial
role in bone metabolism. The action of 1,25-(OH)2D3 is mediated through a specific
hormone receptor (Ralston & de Crombrugghe, 2006). Mutations in the VDR gene cause
the syndrome of vitamin D-resistant rickets, which is a recessive condition characterized
by alopecia, hypocalcaemia, hypophosphatemia, and severe rickets and is resistant to
treatment with vitamin D and its active metabolites (Kristjansson et al., 1993; Ralston
& de Crombrugghe, 2006). VDR was the first candidate gene to be studied in relation to
osteoporosis (Morrison et al., 1994; corrected in 1997), and most attention has focused
on polymorphisms situated near the 3′ end of VDR that are recognized by the restriction
enzymes BsmI, ApaI and TaqI (Ralston & de Crombrugghe, 2006).
The discrepancies between studies addressing genetic risks may be attributed to
genetic heterogeneity, population admixture and gene-environment or gene-gene
interactions (Salanti, Sanderson & Higgins, 2005). Although many studies have been
conducted, the results have given rise to a plethora of arguments on both sides of this
issue (Uitterlinden et al., 2006; Ji et al., 2010). Hence, the results from numerous studies
are inconclusive, and there is still no clear answer whether a specific VDR genotype is
associated with lower BMD.
This study aims to investigate the relationship of a commonly studied polymorphism in
the VDR gene intron 8, BsmI, with BMD in a cohort of Spanish postmenopausal women.
MATERIALS & METHODS
Study population
Participants were 210 unrelated healthy postmenopausal women 60 ± 8 years of age who
were recruited voluntarily from February to December 2013. The group included 150
women with osteoporosis, 30 women with osteopenia and 30 healthy individuals. The
study was performed in accordance with the Declaration of Helsinki and was approved
by the Research Ethics Committee of the University of Extremadura. Written informed
consent was obtained from all subjects.
Densitometric study
Densitometric measurements were performed to define the BMD in the femoral neck
(FN), femoral trochanter (FT), Ward’s triangle (WT) and the lumbar spine at the L2, L3,
L4 and L2-L4 levels. Additionally, body weight and height were measured to calculate the
body mass index (BMI). Densitometric tests were performed with the use of a NORLAND
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XR-800 (Norland Medical Systems, Inc., White Plains, New York, USA). BMD scores were
expressed as grams per square centimeter.
Laboratory analysis
The following SNP was included: rs1544410 (BsmI). SNP was evaluated by allelic
discrimination real-time PCR using a TaqMan probe (Applied Biosystems, Foster City,
California, USA). The PCR consisted of a hot start at 95 ◦C for 10 min followed by 40 cycles
of 94 ◦C for 15 s and 60 ◦C for 1 min. Fluorescence detection occurred at a temperature of
60 ◦C. All assays were performed in 10-µl reactions using TaqMan Genotyping Master Mix
in 48-well plates on a StepOne® instrument (Applied Biosystems, Foster City, California,
USA). Control samples representing all possible genotypes and a negative control were
included in each reaction. The concordance of blinded quality control samples was 100%.
Covariate assessment
Total dietary vitamin D, calcium and energy intake were assessed via validated frequency
questionnaires as previously described (Calderon-Garcia et al., 2013; Moran et al., 2013).
Statistical analysis
Allelic and genotypic frequencies were estimated by gene counting, and the goodness of
fit of the genotype distribution for Hardy-Weinberg equilibrium (HWE) was tested by
chi-square (χ2) test. Value of P > 0.05 indicated HWE.
Statistical analysis of the results was performed with SPSS 20 for Windows. Normal
distribution and homogeneity of variances were assessed using the Kolmogorov–Smirnov
and Levene tests, respectively. Analysis of variance (ANOVA) was used to compare different
genotypes in each SNP followed by Bonferroni’s post-hoc test. Analysis of co-variance
(ANCOVA) was used to compare the VDR genotypes adjusted for the co-variants age,
BMI, years since menopause and daily calcium intake. A few variables were not normally
distributed, and a bootstrap procedure was applied to the ANCOVA test. In that case,
comparisons were performed with a non-parametric Kruskal Wallis test. Significance was
set at P < 0.05.
RESULTS
The baseline characteristics of the 210 unrelated postmenopausal women are summarized
in Table 1.
The distribution of the BsmI genotype and alleles in the studied sample are shown in
Table 2.
Genotype frequencies at the two polymorphic sites agreed closely with Hardy-Weinberg
ratios (P > 0.2). No baseline characteristic showed a significant difference between
genotypes (Table 3).
The BsmI genotype was not related to BMD at any of the studied locations (all
with P > 0.05 by ANOVA) (Table 4). A BMD analysis, after adjustment for potential
confounding factors, such as age, BMI, and years since menopause, revealed no statistically
significant differences between the genotypes (all with P > 0.05 by ANCOVA) (Table 4).
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Table 1 Baseline characteristics of the studied sample.
Mean SD Min Max
Age (y) 60 8 42 78
Weight (kg) 62.9 10 42.6 92.3
Height (m) 1.54 0.06 1.39 1.68
BMI (kg/m2) 26.6 4.3 17.83 39.43
Menarche age (y) 12.9 1.45 9 16
Years since menopause (y) 13.1 8.8 0 38
Daily vitamin D intake (µg) 8.78 15.72 0.36 169.2
Daily calcium intake (mg) 1186.76 500.57 200 3169
Daily Kcal intake (kcalories) 2266 685.6 998.6 4452.8
BMD FN (g/cm2) 0.736 0.118 0.401 1.139
BMD FT (g/cm2) 0.579 0.107 0.268 0.955
BMD TW (g/cm2) 0.518 0.113 0.235 0.989
BMD L2 (g/cm2) 0.802 0.157 0.431 1.380
BMD L3 (g/cm2) 0.808 0.167 0.401 1.385
BMD L4 (g/cm2) 0.779 0.159 0.416 1.316
BMD L2-L4 (g/cm2) 0.796 0.156 0.418 1.310
Table 2 Distribution of the BsmI restriction site genotypes and alleles in the studied sample.
Genotype (%) Allele P
Bb bb BB b B
BsmI 45.2 (95/210) 41.4 (87/210) 13.3 (28/210) 0.6405 0.3595 0.79
Table 3 Distribution of baseline characteristics between the BsmI restriction site genotypes in the
studied sample.
BsmI vitamin D receptor genotype
bb (87) Bb (95) BB (28)
Mean ± SD Mean ± SD Mean ± SD P-value
Age (y) 60 ± 8 60 ± 8 61 ± 9 0.78
Weight (kg) 61.9 ± 10 64.0 ± 9.9 62.1 ± 10.4 0.37
Height (m) 1.54 ± 0.05 1.54 ± 0.06 1.53 ± 0.06 0.86
BMI (kg/m2) 26.07 ± 4.02 27.10 ± 4.5 26.49 ± 4.41 0.34
Menarche age (y) 13.03 ± 1.44 12.79 ± 1.46 12.78 ± 1.47 0.48
Years since menopause (y) 12.8 ± 8.1 12.6 ± 9.1 15.7 ± 9.5 0.31
Daily vitamin D intake (µg) 8.15 ± 6.56 9.66 ± 2.17 7.62 ± 9.03 0.57
Daily calcium intake (mg) 1156.84 ± 496.88 1198.21 ± 428.25 1232.68 ± 705.52 0.61
Daily Kcal intake (kcalories) 2162.6 ± 574.6 2354.7 ± 756.2 2260.5 ± 710.1 0.4
Based on the FN T-score or the L2-L4 T-score, women were classified as normal (30
subjects, 14.3% of the study population), osteopenic (30 subjects, 14.3%), or osteoporotic
(150 subjects, 71.4%) following the World Health Organization criteria (Kanis et al.,
2002). The demographic, biological, major nutritional values and densitometric figures
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Table 4 BMD at the FN, FT, WT, L2, L3, L4 and L2-L4 according to the VDR BsmI. Data shown are mean ± SD, and P values obtained from ANOVA and ANCOVA.
The BMD values are shown as BMD1 and BMD2, which denotes the raw BMD, and BMD adjusted for age, BMI, years since menopause and calcium intake respectively.
BB (28) Bb (95) bb (87) P-value BB (28) Bb (95) bb (87) P-value
FN 0.739 ± 0.934 0.747 ± 0.129 0.725 ± 0.111 0.46 0.723 ± 0.088 0.743 ± 0.122 0.713 ± 0.101 0.49
FT 0.580 ± 0.090 0.586 ± 0.122 0.571 ± 0.094 0.61 0.569 ± 0.094 0.582 ± 0.112 0.558 ± 0.085 0.64
TW 0.523 ± 0.087 0.525 ± 0.129 0.509 ± 0.101 0.61 0.506 ± 0.077 0.522 ± 0.119 0.504 ± 0.093 0.8
L2 0.781 ± 0.131 0.819 ± 0.178 0.790 ± 0.138 0.33 0.762 ± 0.110 0.808 ± 0.166 0.778 ± 0.131 0.25
L3 0.786 ± 0.131 0.931 ± 0.197 0.791 ± 0.136 0.2 0.764 ± 0.089 0.816 ± 0.187 0.776 ± 0.125 0.38
L4 0.760 ± 0.130 0.796 ± 0.192 0.756 ± 0.125 0.34 0.748 ± 0.119 0.781 ± 0.185 0.755 ± 0.116 0.76
BMD1 (g/cm2)
L2-L4 0.775 ± 0.125 0.815 ± 0.187 0.783 ± 0.126 0.29
BMD2 (g/cm2)
0.757 ± 0.099 0.799 ± 0.175 0.771 ± 0.115 0.63
Notes.











Table 5 Demographic, biological, major nutritional and densitometric figures for osteoporotic, osteopenic and normal subjects in the studied
sample.
NORMAL (30) OSTEOPENIC (30) OSTEOPOROTIC (150)
Mean SD Mean SD Mean SD P-value
Age 59.73 9.28 60.77 8.19 60.24 7.74 0.884
Menarche age 12.7 1.34 13.4 1.47 12.82 1.45 0.105
Years since menopause 12.76 8.23 13.37 9.31 13.08 8.8 0.968
Pregnancies 3 2 3 2 3 2 0.352
Weight (kg) 68.8 7.9 64.6 12 61.3 9.5 0.001a
Height (m) 1.56 0.05 1.54 0.049 1.53 0.057 0.041b
BMI (kg/m2) 28.29 3.9 37.34 5.39 26.1 4.051 0.022c
Daily vitamin D intake (µg) 0.007 0.007 0.006 0.007 0.009 0.017 0.677
Daily calcium intake (mg) 1077.32 471.995 1240.269 559.722 1194.826 493.896 0.504
Daily Kcal intake (kcalories) 2084.52 626.98 2239 799.52 2302.68 670.52 0.38
BMD FN (g/cm2) 0.91 0.092 0.748 0.065 0.699 0.097 P < 0.0001
BMD FT (g/cm2) 0.736 0.087 0.577 0.083 0.548 0.085 P < 0.0001
BMD TW (g/cm2) 0. 682 0.101 0.529 0.075 0.483 0.09 P < 0.0001
BMD L2 (g/cm2) 1.124 0.092 0.806 0.047 0.737 0.085 P < 0.0001
BMD L3 (g/cm2) 0.154 0.126 0.796 0.092 0.742 0.076 P < 0.0001
BMD L4 (g/cm2) 1.115 0.096 0.803 0.042 0.706 0.073 P < 0.0001
BMD L2-L4 (g/cm2) 1.134 0.094 0.804 0.036 0.727 0.156 P < 0.0001
Notes.
a Normal vs Osteoporosis P = 0.01; Normal vs Osteopenia P = 0.298; Osteopenia vs Osteoporosis P = 0.282 by post hoc Bonferroni test.
b Normal vs Osteoporosis P = 0.035; Normal vs Osteopenia P = 0.363; Osteopenia vs Osteoporosis P = 1.000 by post hoc Bonferroni test.
c Normal vs Osteoporosis P = 0.032; Normal vs Osteopenia P = 1.000; Osteopenia vs Osteoporosis P = 0.437 by post hoc Bonferroni test.
for osteoporotic, osteopenic and normal subjects are shown in Table 5. The osteoporotic
women’s height, weight, and BMI were significantly lower than those of normal women
(P < 0.05 by ANOVA). No statistically significant differences were found in age, menarche
age, years since menopause, and daily intakes of calcium, vitamin D and kilocalories
(P > 0.05 by ANOVA) (Table 5).
The relationship between VDR gene genotypes and the BMD of osteoporotic,
osteopenic and normal subjects is shown in Table 6. The BMD at L2 was lower in
osteopenic women with the Bb genotype than in those carrying bb (P = 0.031), but
after further adjustment by age, BMI and YSM, this difference was no longer statistically
significant (P = 0.053).
DISCUSSION
Genetic association studies in osteoporosis often bring discrepant results. Our study
found no direct association between BMD and specific genotypes of the analyzed VDR
polymorphism. Our results are also consistent with previous studies, (Uitterlinden et al.,
1996; Fang et al., 2006; Horst-Sikorska et al., 2013) in which no relationship between VDR
polymorphisms BsmI, ApaI or other (TaqI and FoqI) and BMD was found. Moreover,
in postmenopausal women undergoing antiresorptive treatment, therapy response was
independent of the BsmI genotype (Conti et al., 2015). However, a meta-analysis by
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Table 6 VDR BsmI genotype and BMD of osteoporotic, osteopenic and normal women.
NORMAL OSTEOPENIA OSTEOPOROSIS
bb (8) Bb (19) BB (3) P-value bb (12) Bb (11) BB (7) P-value bb (67) Bb (65) BB (18) P-value
DMO FN (g/cm2) 0.929 ± 0.089 0.910 ± 0.099 0.864 ± 0.006 0.295 0.739 ± 0.071 0.763 ± 0.058 0.740 ± 0.070 0.641 0.698 ± 0.093 0.696 ± 0.104 0.718 ± 0.095 0.552
DMO FT (g/cm2) 0.766 ± 0.111 0.735 ± 0.073 0.663 ± 0.088 0.224 0.556 ± 0.034 0.586 ± 0.122 0.603 ± 0.070 0.442 0.551 ± 0.071 0.544 ± 0.098 0.557 ± 0.091 0.722
DMO TW (g/cm2) 0.712 ± 0.093 0.676 ± 0.109 0.639 ± 0.060 0.47 0.513 ± 0.055 0.540 ± 0.105 0.540 ± 0.053 0.585 0.484 ± 0.080 0.479 ± 0.103 0.498 ± 0.087 0.821
DMO L2 (g/cm2) 1.147 ± 0.114 1.125 ± 0.086 1.060 ± 0.045 0.373 0.826 ± 0.040 0.778 ± 0.048 0.818 ± 0.041 0.013a 0.741 ± 0.073 0.738 ± 0.097 0.721 ± 0.092 0.407
DMO L3 (g/cm2) 1.138 ± 0.109 1.169 ± 0.140 1.105 ± 0.079 0.777 0.782 ± 0.123 0.807 ± 0.084 0.805 ± 0.024 0.881 0.751 ± 0.065 0.737 ± 0.088 0.727 ± 0.069 0.316
DMO L4 (g/cm2) 1.09 ± 0.094 1.132 ± 0.097 1.055 ± 0.090 0.352 0.803 ± 0.020 0.800 ± 0.067 0.810 ± 0.016 0.778 0.719 ± 0.060 0.698 ± 0.086 0.691 ± 0.066 0.393
DMO L2-L4 (g/cm2) 1.127 ± 0.097 1.146 ± 0.099 1.074 ± 0.026 0.355 0.814 ± 0.012 0.792 ± 0.057 0.811 ± 0.011 0.461 0.737 ± 0.055 0.722 ± 0.082 0.711 ± 0.064 0.355
Notes.











Thakkinstian and co-workers (2004) revealed a weak but statistically significant association
between the B allele and lower BMD in the lumbar spine; these results support a former
paper from Morrison et al. (1994) that reported lower BMD in BsmI BB homozygotes.
Recently, a meta-analysis from Wang and colleagues (2013) found an association of BMD
with BsmI and ApaI polymorphisms in postmenopausal Asian women (especially Indian
women), suggesting that the racial/ethnic genetic background plays a role. In addition, Jia
and colleagues (2013) recently found an association of the VDR BsmI polymorphism with
a protective role against the development of osteoporosis in postmenopausal women using
a meta-analysis of 26 studies. At this point, studies have reported controversial results, and
no conclusion about the role of common VDR polymorphisms on BMD can be drawn yet.
Hence, discordant results may be due to the different populations studied/racial
differences in BMD. A study by Morrison et al. (1994) was conducted among an ethnically
diverse Australian population, which was additionally exposed to higher doses of UVB
radiation and potentially higher amounts of active vitamin D.
VDR gene expression is likely affected by environmental factors. Several authors
suggested that calcium homeostasis might play a role in this process. Stathopoulou and
colleagues (2011) showed that, under lower calcium intake (<680 mg/day), the presence
of the B allele of the BsmI polymorphism increased the risk of osteoporosis by 118%.
In the presence of higher calcium intake, the influence of the VDR alleles on BMD was
nearly insignificant. Thus, adequate calcium intake appears to counteract the genetic
influence of VDR on the bone, and this effect that could be observed in our study. In fact,
participants in our study had a daily calcium intake of 1186.76 mg, which was almost
double the amount reported by Stathopoulou and colleagues (2011). We hypothesize
that these findings further support the hypothesis that environmental factors, especially
dietary calcium, may modulate the genotype-phenotype relationship, and therefore have a
significant impact on the obtained results.
Thus, an important environmental-gene interaction exists between VDR polymor-
phisms, including BsmI variants, and calcium or calcitriol intake. The first evidence for
an interaction between calcium intake and the BsmI VDR polymorphism came from
a study by Ferrari et al. (1995) in a sample of elderly patients receiving calcium and
calcitriol supplements, among whom BMD loss was higher in the lumbar spine of the
BB homozygotes. Additionally, the BB genotype is associated with a higher response to
calcium administration, reduced efficiency of calcium absorption and low response of
BMD (Gennari et al., 1997). Furthermore, a large-scale population-based study from
MacDonald and colleagues (2006) reported evidence of weak interactions between calcium
intake, VDR variants and BMD with rates of bone loss in a manner that favored the bb
homozygotes in the lowest calcium intake quartile.
Additionally, the BsmI polymorphism is located in the non-coding region of the VDR
gene, and they do not have an effect on the final protein product (Uitterlinden et al., 2004;
Fang et al., 2005). The B allele correlate with enhanced mRNA stability or transcriptional
activity and greater vitamin D activity (Morrison et al., 1994). Overall, this fact highlights
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the importance of understanding the mechanisms by which these polymorphisms affect
VDR action.
In Spain, 719 postmenopausal women were genotyped for common VDR polymor-
phisms (Bustamante et al., 2007), and a lack of relevance for osteoporosis and these
polymorphisms was found. Our results agree with this much larger study in Spanish
postmenopausal women. In a cohort of 177 Spanish postmenopausal women, Bandres and
colleagues (2005) did not find an association of BMD with the BsmI gene polymorphism
after further adjustment for potential confounding factors (weight, age and years since
menopause). Similar results were found in a smaller study from Fontova Garrofé and
colleagues (2000) (for the BsmI polymorphism). However, in a cohort of 204 Spanish
postmenopausal women, a significantly lower BMD was observed in BB subjects (Bernad
et al., 1999). Interestingly, 60% of the studied sample had an intake of calcium lower than
500 mg/day, and these numbers are in the range reported by Stathopoulou and colleagues
(2011). This result could support the reported association because the calcium intake
would not mask the VDR genetic influence on bone in the study by Bernard and colleagues.
Our study was limited by the modest sample size, which did not have sufficient statistical
power for the detection of subtle effects; therefore, there might be type II errors.
CONCLUSIONS
In conclusion, we found no significant association between the common VDR polymor-
phism BsmI and BMD at any skeletal site in a sample of Spanish postmenopausal women.
Previous studies in Spain have examined the association between BMD and the VDR
polymorphism BsmI, and to date, our study is one of the highest in sample size. The
results reported should be interpreted cautiously because of the small sample size. Future
studies in larger samples of Spanish postmenopausal women focused in the study of the
different haplotypes, instead of a single polymorphism will help to clarify potential effects
of common VDR polymorphisms.
ADDITIONAL INFORMATION AND DECLARATIONS
Funding
The authors declare there was no funding for this work.
Competing Interests
The authors declare there are no competing interests.
Author Contributions
• Jose M. Moran conceived and designed the experiments, performed the experiments,
analyzed the data, contributed reagents/materials/analysis tools, wrote the paper,
prepared figures and/or tables, reviewed drafts of the paper.
• Maria Pedrera-Canal conceived and designed the experiments, performed the
experiments, contributed reagents/materials/analysis tools, prepared figures and/or
tables.
Moran et al. (2015), PeerJ, DOI 10.7717/peerj.953 9/12
• Francisco J. Rodriguez-Velasco, Vicente Vera, Jesus M. Lavado-Garcia and Pilar
Fernandez performed the experiments, contributed reagents/materials/analysis tools.
• Juan D. Pedrera-Zamorano conceived and designed the experiments, analyzed the data,
wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.
Human Ethics
The following information was supplied relating to ethical approvals (i.e., approving body
and any reference numbers):
The study was performed in accordance with the Declaration of Helsinki and was
approved by the Research Ethics Committee of the University of Extremadura. Written
informed consent was obtained from all subjects.
Supplemental Information
Supplemental information for this article can be found online at http://dx.doi.org/
10.7717/peerj.953#supplemental-information.
REFERENCES
Bandres E, Pombo I, Gonzalez-Huarriz M, Rebollo A, Lopez G, Garcia-Foncillas J. 2005.
Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1
and CTR genes in Spanish postmenopausal women. Journal of Endocrinological Investigation
28:312–321 DOI 10.1007/BF03347196.
Bernad M, Jaramillo G, Aguado P, del CT, Coya J, Martin ME, Gijón Baños J, Saldaña
Barrera H, Martı́nez ME. 1999. Polymorphism of the gene of vitamin D receptor and bone
mineral density in postmenopausal women. Medicina Clinica 112:651–655.
Bustamante M, Nogués X, Enjuanes A, Elosua R, Garcı́a-Giralt N, Pérez-Edo L, Cáceres E,
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